“Our donors have allowed top scientific minds to explore this new and promising avenue of cancer treatment, and their philanthropy is directly linked to the lives saved so far,” said Barbara Netter, President and Co-Founder of ACGT.
Read the press release.
Bristol-Myers, Merck and Roche Develop Drugs to Zap Tumors Via Immune System by Ron Winslow and Peter Loftus, Wall Street Journal
As genetically targeted therapies gain ground against cancer, another treatment strategy called immunotherapy is emerging as a potentially powerful new partner against malignancies.
Read the article.
Breaking Through Cancer’s Shield by Gina Kolata, New York Times
When the immune system is free to attack, cancers can shrink and stop growing or even disappear in lucky patients with the best responses. It may not matter which type of cancer a person has. What matters is letting the immune system do its job.
Read the article.